Key result
Novel antimicrobial PLDLA-TMC vascular scaffolds inhibit S. aureus while preserving ~73% endothelial cell viability.
Answers are grounded in this paper and cite their sources.
Research develops 3D-printed vascular scaffolds with enhanced mechanical properties and antibacterial coatings, indicating improved integration and infection resistance.
Background: Synthetic vascular scaffolds often exhibit limited mechanical performance and low hydrophilicity, which compromise early vascular integration and increase susceptibility to bacterial colonization. This study developed 3D-printed scaffolds based on poly(L-co-D,L-lactide)–poly(trimethylene carbonate) (PLDLA–TMC) with polyethylene glycol 400 (PEG) to modulate mechanical and interfacial properties and coated with poly(hexamethylene biguanide) (PHMB) to confer antibacterial activity. Methods: PLDLA–TMC scaffolds modified with PEG 400 and coated with PHMB were prepared and systematically characterized to assess their structural, thermal, mechanical, and antimicrobial properties. PHMB coatings (3%, 6%, and 12% w/w in hydroxypropyl methylcellulose, HPMC) were applied and evaluated for drug release, cytotoxicity, and activity against Staphylococcus aureus. Biocompatibility was tested in an endothelial cell and myoblast co-culture. Results: Incorporation of 2% PEG increased the tensile strength from 0.14 ± 0.10 MPa for scaffolds containing 0.5% PEG to 0.79 ± 0.12 MPa and promotes a more elastic scaffold behavior. PHMB at 12% caused cytotoxicity (7.70 ± 0.37% cell viability). The 3% PHMB coating produced a 12.5 ± 0.1 mm inhibition zone but exhibited burst release within 1 h, whereas the 6% coating maintained cell viability (72.95 ± 1.10%), produced a 13.1 ± 0.2 mm inhibition zone, and provided sustained antimicrobial release over 7 days. Scaffolds supported organized adhesion and proliferation of endothelial cells and myoblasts. Conclusions: 3D-printed PLDLA–TMC scaffolds containing 2% PEG and coated with 6% PHMB combined improved mechanical performance, sustained antimicrobial release, antibacterial activity, and biocompatibility in an in vitro vascular model.
No takes yet. Share an insight, caveat, or question.
Munhoz et al. (2026) studied Vascular graft infection and mechanical incompatibility in vascular replacement. 3D-printed PLDLA-TMC + 2.0% PEG 400 scaffold coated with 6% PHMB in HPMC vs. Uncoated PLDLA-TMC + PEG scaffolds (0.5% or 2.0% PEG) or cell-only control was evaluated on Endothelial cell viability (indirect MTT cytotoxicity assay at 24 h) (p=<0.001). 3D-printed PLDLA-TMC scaffolds with 2% PEG and 6% PHMB increased tensile strength to 0.79 MPa, sustained 7-day release, inhibited S. aureus, and kept 72.95% cell viability.
Synapse has enriched 10 related papers. Consider them for comparative context: